Annexin Pharmaceuticals Stock Forward View - Polynomial Regression
| ANNX Stock | SEK 13.40 0.20 1.52% |
The Polynomial Regression forecast reference data for Annexin Pharmaceuticals AB is based on the equity's recent trading history. Forecast values and accuracy indicators are summarized on this page for reference. This reference information is provided for analytical context.
The Polynomial Regression forecasted value of Annexin Pharmaceuticals AB on the next trading day is expected to be 12.34 with a mean absolute deviation of 0.96 and the sum of the absolute errors of 59.34.A single variable polynomial regression model attempts to put a curve through the Annexin Pharmaceuticals historical price points. Mathematically, assuming the independent variable is X and the dependent variable is Y, this line can be indicated as: Y = a0 + a1*X + a2*X2 + a3*X3 + ... + am*Xm The Polynomial Regression projections for Annexin Pharmaceuticals AB are reference data based on historical daily prices and are provided as informational context. Polynomial Regression Price Forecast For the 27th of March
Given 90 days horizon, the Polynomial Regression forecasted value of Annexin Pharmaceuticals AB on the next trading day is expected to be 12.34 with a mean absolute deviation of 0.96 , mean absolute percentage error of 2.02 , and the sum of the absolute errors of 59.34 .Please note that although there have been many attempts to predict Annexin Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Annexin Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Annexin Pharmaceuticals | Annexin Pharmaceuticals Price Prediction | Research Analysis |
Forecasted Value
For the next trading day, Macroaxis evaluates Annexin Pharmaceuticals' predictive range by looking for statistically meaningful downside and upside boundaries. The current forecast range spans downside near 5.85 and upside near 18.83.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Annexin Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Annexin Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.651 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.957 |
| MAPE | Mean absolute percentage error | 0.0577 |
| SAE | Sum of the absolute errors | 59.3359 |
Other Forecasting Options for Annexin Pharmaceuticals
Volatility clustering is a well-documented feature of Annexin Stock price data where periods of large moves tend to follow other large moves. When Annexin Pharmaceuticals' RSI reaches extreme levels, it often precedes a short-term price correction or consolidation. Seasonal patterns in Annexin Pharmaceuticals' returns can persist when driven by structural factors like earnings calendars or index rebalancing.Annexin Pharmaceuticals Related Equities
Investors studying Annexin Pharmaceuticals often look at related stocks within the Biotechnology space to gauge pricing and results. Return on equity across these peers shows how well each firm turns capital into profit. Sector-wide trends across this peer group can help split company-level factors from broader forces.
| Risk & Return | Correlation |
Annexin Pharmaceuticals Market Strength Events
Analyzing market strength indicators for Annexin Pharmaceuticals enables investors to understand relative stock momentum. These tools help identify favorable windows for position changes in Annexin Pharmaceuticals AB. Market strength indicators support more precise timing of Annexin Pharmaceuticals AB positions across market cycles.
Annexin Pharmaceuticals Risk Indicators
Identifying and analyzing Annexin Pharmaceuticals' key risk indicators is a foundational step in projecting how its price may evolve. This process involves measuring the level of investment risk in Annexin Pharmaceuticals' and determining how best to manage it. Studying Annexin Pharmaceuticals' risk indicators helps investors understand the risk level of annexin stock.
| Mean Deviation | 4.06 | |||
| Standard Deviation | 6.3 | |||
| Variance | 39.73 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Annexin Pharmaceuticals
The amount of media and story coverage tied to Annexin Pharmaceuticals AB can signal where market attention is concentrating at the moment. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
Annexin Pharmaceuticals Short Properties
Short sentiment tied to Annexin Pharmaceuticals AB matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 92.3 M | |
| Cash And Short Term Investments | 49.5 M |
Additional Tools for Annexin Stock Analysis
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |